Astria Therapeutics, Inc. (ATXS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 9.35 |
| Open | 9.59 |
| Bid | 9.52 x 200 |
| Ask | 9.56 x 400 |
| Day's Range | 9.36 - 9.86 |
| 52 Week Range | 4.26 - 16.90 |
| Volume | |
| Avg. Volume | 1,038,050 |
| Market Cap | 524.42M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc (ATXS)
Astria Therapeutics Inc (NASDAQ:ATXS), a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat debilitating diseases, has reported an insider sale according to a recent SEC filing.
- Simply Wall St.
Astria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the company
Key Insights Significantly high institutional ownership implies Astria Therapeutics' stock price is sensitive to their...
- GuruFocus.com
Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc
Christopher Morabito, Chief Medical Officer of Astria Therapeutics Inc (NASDAQ:ATXS), has sold 10,000 shares of the company on January 29, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.